According to microarray results, we confirmed these four genes were the targets of SFE in esophageal cancer cells, and SFE could inhibit esophageal cancer progression through suppressing SCD and CDH3 expression, and activating the GADD45B-MAP2K3-p38-p53 feedback loop. This evidence concerns the gene MAP2K3 and esophageal cancer.